Joachim Schultze

from Wikipedia, the free encyclopedia

Joachim L. Schultze (born April 30, 1965 in Heidenheim an der Brenz ) is a German immunologist, cancer and genome researcher.

Life

After studying medicine in Tübingen, he began his medical training in 1991 at the Clinic for Hematology and Oncology at the Freiburg University Hospital. In 1993 he moved to the Dana-Farber Cancer Institute at Harvard Medical School in Boston , where he worked with Lee Nadler on the development of new treatments for cancer. In 2002 he accepted a C3 endowed professorship for tumor immunology at the University of Cologne Clinic . In 2004 he founded the Virtual Institute for Interdisciplinary Prevention Research together with a national team of experts . In November 2007 Joachim Schultze received the W3 professorship for Genomics and Immunoregulation at the LIMES Institute of the University of Bonn. Schultze heads the department of the same name for Genomics and Immunoregulation.

His research focuses on genome research, the regulation of the immune system, improving the vaccination rate in the population and protecting against pandemics.

As a co-founder of a company, he is also concerned with improving vaccination coverage in the population and with risk management for pandemic influenza. The company he co-founded has already developed two products for this purpose.

Awards

  • 1997: Fellowship Award from the Lymphoma Research Foundation of America
  • 1998: Special Fellowship Award from the Leukemia & Lymphoma Society
  • 1999: Translational Research Award from the Leukemia & Lymphoma Society
  • 2000: Senior Investigator Award from the Multiple Myeloma Research Foundation
  • 2002: Sofja Kovalevskaja Prize from the Alexander von Humboldt Foundation

Web links